Managing three mega-trials with unique supply constraints: Creative approaches using IXRS®3 to mitigate risk of inventory disruptions

When a top-tier pharmaceutical company was planning three mega-trials in the cardiovascular space, it turned to Almac Clinical Technologies to provide the supporting IRT system. The company knew from experience that Almac’s IXRS®3 could handle the volume and complexity of these trials which would enroll nearly 50,000 patients in total. It also was counting on Almac to find ways to mitigate the risks associated with the scarcity of investigational product. Their confidence was well placed.